Colorectal cancer (CRC) screening, the decade's most promising cancer-related public health development, is evolving. Faecal immunochemical tests (FIT) will be the primary population-based CRC screening biomarker for the next 10–15 years. Will the international community exploit the full potential of FIT and other CRC risk indicators to enable a revolution in the effectiveness of screening?
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Kapidzic, A. et al. Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am. J. Gastroenterol. Gut 109, 1257–1264 (2014).
Hol, L. et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59, 62–68 (2010).
van Roon, A. H. C. et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut 62, 409–415 (2013).
Lo, S. H. et al. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut http://dx.doi.org/10.1136/gutjnl-2013-306144.
Gupta, S. et al. Challenges and possible solutions to colorectal cancer screening for the underserved. J. Natl Cancer Inst. 106, dju032 (2014).
Quintero, E. et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N. Engl. J. Med. 366, 697–706 (2012).
Steele, R. J. C. et al. Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity. United European Gastroenterol. J. 1, 198–205 (2013).
Grazzini, G. et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br. J. Cancer 100, 259–265 (2009).
Terhaar sive Droste, J. S. et al. Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers. Cancer Epidemiol. Biomarkers Prev. 20, 272–280 (2011).
Chen, L. S. et al. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet 12, 551–558 (2011).
S.P.H. acknowledges support from The NHS Bowel Cancer Screening Programme, Royal Surrey County Hospital NHS Foundation Trust and University of Surrey.
The author declares no competing financial interests.
About this article
Cite this article
Halloran, S. Colorectal cancer screening—insights and challenges. Nat Rev Gastroenterol Hepatol 11, 586–587 (2014). https://doi.org/10.1038/nrgastro.2014.150